Objective
IMMUNOSHAPE aims at training a new generation of scientists that will be capable of combining state of the art synthesis and screening technology to develop new lead structures for highly selective glycan based multivalent immunotherapeutics for the treatment of cancer, autoimmune diseases and allergy. To this end, we have set up a training program in a unique academic-industrial environment that will educate young researchers in scientific and practical biomedical glycoscience with the final aim to produce new talent and innovation in the field and improve their career perspectives in both academic and non-academic sectors. The unique combination of 10 academic groups with expertise in automated solid-phase carbohydrate synthesis, microarray based highthroughput screening technology, tumour immunology, structural glycobiology, multivalent systems and medicinal chemistry along with 4 industrial partners active in nanomedicine, immunotherapy, medicinal device development and the fabrication of scientific instrumentation will provide a multidisciplinary and multisectorial training to 15 ESRs in biomedical glycoscience and its industrial applications.
Fields of science
- medical and health sciencesmedical biotechnologynanomedicine
- medical and health sciencesbasic medicineimmunologyautoimmune diseases
- natural sciencesbiological sciencesbiochemistrybiomoleculescarbohydrates
- medical and health sciencesclinical medicineallergology
- medical and health sciencesbasic medicineimmunologyimmunotherapy
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
20009 San Sebastian
Spain
See on map
Participants (14)
45520 Chevilly
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
20122 Milano
See on map
38058 Grenoble
See on map
28006 Madrid
See on map
Participation ended
1081 HV Amsterdam
See on map
69120 Heidelberg
See on map
80539 Munchen
See on map
2311 EZ Leiden
See on map
14476 Potsdam
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
M13 9PL Manchester
See on map
3621 ZA Breukelen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
48160 Derio
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
30559 Hannover
See on map
1081 HV Amsterdam
See on map
Partners (1)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
53100 SIENA
See on map